P-159Analysis of early tumor shrinkage and depth of response in metastatic pancreatic cancer patients treated with first-line modified FOLFIRINOX or gemcitabine + nab-paclitaxel. (20th June 2018) - Vivaldi, C; Cappelli, C; Donati, F; Fornaro, L; Musettini, G; Pasquini, G; Pecora, I; Catanese, S; Lencioni, M; Salani, F; Boraschi, P; Falcone, A; et al.